Navigation Links
2010 Chemistry Nobel laureate Ei-ichi Negishi leads C&EN webinar

WASHINGTON, Oct. 7, 2010 Ei-ichi Negishi, Ph.D., who just shared the 2010 Nobel Prize in Chemistry, will lead a Chemical & Engineering News (C&EN) webinar Oct. 12 on the discovery, development and application of the famed ZACA reaction. C&EN is the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.

That landmark chemical reaction provides new ways of making medicines and other key products using green chemistry methods, which minimize or avoid the use of potentially toxic substances. ZACA stands for zirconium-catalyzed asymmetric carboalumination of alkenes.

The webinar, sponsored by Aldrich Chemistry, will be broadcast live from Purdue University, West Lafayette, Ind., at 9:30 a.m. EDT as part of the fifth annual two-day Negishi-Brown and Catalytic Asymmetric and Other Selective Syntheses (CAOSS) Lectures. Stu Borman, deputy assistant managing editor of C&EN, will moderate the session.

The webinar will focus on the ZACA reaction's discovery, development, and application to "green and economical" syntheses of biologically and medicinally important "chiral" organic compounds for the benefit of mankind; the efficient and selective synthesis of chiral natural products; the synthesis of vitamins E and K and other compounds of dietary and medicinal interest; and other important aspects of the reaction. A live question and answer period will follow.

To take part in the webinar, go to All Web registrants can ask questions during the live event.


Contact: Michael Bernstein
American Chemical Society

Page: 1

Related medicine news :

1. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
2. Tastier MRE: Chemistry gives battlefield chow a gourmet flare
3. Subtyping breast cancer by immunohistochemistry to investigate survival terms
4. Basque researchers apply chemistry to restoration of paintings and dating of signatures
5. Pfizer joins open-access medicinal chemistry public-private collaboration
6. MIT moves toward greener chemistry
7. Learning Lab of Brentwood Leads Free ADHD Seminar
8. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
9. TechCFO Enters Mid-Atlantic Market; Rick Rolandi Leads DC Metro Office
10. Home Health Agency Owner Pleads Guilty in Connection with Detroit Fraud Scheme
11. New DNA technique leads to a breakthrough in child cancer research
Post Your Comments:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: